LU82295A1 - Agents therapeutiques et leur procede de preparation - Google Patents

Agents therapeutiques et leur procede de preparation Download PDF

Info

Publication number
LU82295A1
LU82295A1 LU82295A LU82295A LU82295A1 LU 82295 A1 LU82295 A1 LU 82295A1 LU 82295 A LU82295 A LU 82295A LU 82295 A LU82295 A LU 82295A LU 82295 A1 LU82295 A1 LU 82295A1
Authority
LU
Luxembourg
Prior art keywords
group
methyl
quinolone
lower alkyl
hydrogen atom
Prior art date
Application number
LU82295A
Other languages
English (en)
French (fr)
Inventor
R Parkinson
J Fraser
M Sim
R Davies
D Yates
K Nichol
Original Assignee
Boots Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Ltd filed Critical Boots Co Ltd
Publication of LU82295A1 publication Critical patent/LU82295A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/24—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
    • C07D265/26—Two oxygen atoms, e.g. isatoic anhydride
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
LU82295A 1979-03-27 1980-03-25 Agents therapeutiques et leur procede de preparation LU82295A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB7910558 1979-03-27
GB7910558 1979-03-27
GB7939505 1979-11-15
GB7939505 1979-11-15

Publications (1)

Publication Number Publication Date
LU82295A1 true LU82295A1 (fr) 1981-04-17

Family

ID=26271029

Family Applications (1)

Application Number Title Priority Date Filing Date
LU82295A LU82295A1 (fr) 1979-03-27 1980-03-25 Agents therapeutiques et leur procede de preparation

Country Status (34)

Country Link
US (1) US4302460A (da)
KR (1) KR840001612B1 (da)
AT (1) AT379390B (da)
AU (1) AU536616B2 (da)
BG (2) BG37836A3 (da)
CA (1) CA1151652A (da)
CH (1) CH644366A5 (da)
CS (1) CS221906B2 (da)
DD (1) DD149608A5 (da)
DE (2) DE3011994A1 (da)
DK (1) DK151252C (da)
EG (1) EG16606A (da)
FI (1) FI77026C (da)
FR (2) FR2452484A1 (da)
GR (1) GR68007B (da)
HK (1) HK94986A (da)
HU (1) HU179845B (da)
IE (1) IE49562B1 (da)
IL (1) IL59710A (da)
IT (1) IT1188916B (da)
KE (1) KE3649D (da)
LU (1) LU82295A1 (da)
MX (1) MX6816E (da)
MY (1) MY8600668A (da)
NL (1) NL191306C (da)
NO (1) NO156787C (da)
NZ (1) NZ193167A (da)
PH (1) PH16758A (da)
PL (1) PL124037B1 (da)
PT (1) PT71006A (da)
RO (1) RO79397A (da)
SE (1) SE455422B (da)
SG (1) SG60886G (da)
YU (1) YU42332B (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE51542B1 (en) * 1980-09-26 1987-01-07 Boots Co Ltd Therapeutic agents
PT79031B (en) * 1983-08-20 1986-08-22 Boots Co Plc Therapeutic agents
DE3578374D1 (de) * 1984-01-13 1990-08-02 Boots Co Ltd Verwendung von chinolonen fuer die herstellung eines arzneimittels zur behandlung von herzerkrankungen.
DE3576686D1 (de) * 1984-08-15 1990-04-26 Boots Co Ltd Chinolinone, verfahren zu ihrer herstellung und die sie enthaltenden pharmazeutischen praeparate.
GB8515209D0 (en) * 1985-06-15 1985-07-17 Boots Co Plc Therapeutic agents
GB8515207D0 (en) * 1985-06-15 1985-07-17 Boots Co Plc Therapeutic agents
GB8627698D0 (en) * 1986-11-20 1986-12-17 Boots Co Plc Therapeutic agents
GB8726950D0 (en) * 1987-11-18 1987-12-23 Boots Co Plc Chemical process
GB8804016D0 (en) * 1988-02-22 1988-03-23 Boots Co Plc Therapeutic agents
GB8918952D0 (en) * 1989-08-19 1989-10-04 Boots Co Plc Therapeutic agents
FR2680511B1 (fr) * 1991-08-20 1995-05-19 Roussel Uclaf Derives n-substitues de la quinoleine, leur procede de preparation, intermediaires obtenus, leur application comme medicaments et les compositions les renfermant.
FR2672597B1 (fr) * 1991-02-07 1995-05-19 Roussel Uclaf Nouveaux derives n-substitues de la quinoleine, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
FR2684671B1 (fr) * 1991-11-20 1995-05-19 Roussel Uclaf Nouveaux derives de la quinoleine, leur procede de preparation et intermediaires et leur application a titre de medicaments.
IL100555A (en) * 1991-02-07 2000-08-31 Hoechst Marion Roussel Inc N-substituted quinoline derivatives their preparation their use for the preparation of medicaments and the pharmaceutical compositions containing them
JP2002522388A (ja) * 1998-08-03 2002-07-23 ビーエーエスエフ コーポレーション 性機能障害の治療のためのピリジノン
US6307050B1 (en) * 2000-08-29 2001-10-23 R. T. Alamo Venture I Llc Method of synthesizing flosequinan from 4-fluoroanthranilic acid
US6451813B1 (en) 2001-01-26 2002-09-17 R. T. Alamo Ventures I, Llc Treatment of gastroparesis in certain patient groups
US6562838B2 (en) 2001-01-26 2003-05-13 R. T. Alamo Ventures I, L.L.C. Treatment of cardiovascular disease with quinolinone enantiomers
US6458804B1 (en) * 2001-01-26 2002-10-01 R.T. Alamo Venturesi, Llc Methods for the treatment of central nervous system disorders in certain patient groups
US6649764B2 (en) * 2001-10-25 2003-11-18 R. T. Alamo Ventures I, Llc Stereospecific enrichment of heterocyclic enantiomers
US6730790B2 (en) * 2002-03-01 2004-05-04 R.T. Alamo Ventures I. Llc Chlorinated heterocyclic compounds and methods of synthesis

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3178348A (en) * 1961-02-08 1965-04-13 Norwich Pharma Co Hypotensive quinolines
GB1066919A (en) 1964-04-03 1967-04-26 Hoffmann La Roche Novel benzyl amine derivatives
DE1770482A1 (de) * 1968-05-22 1971-11-11 Basf Ag Verfahren zur Herstellung von 2,4-Dioxychinolinen
US3798219A (en) * 1971-10-18 1974-03-19 Warner Lambert Co 3-(methylsulfinyl)cinnolinones and their derivatives
US3772301A (en) * 1971-11-22 1973-11-13 Warner Lambert Co (4-substituted)4-(methylsulfinyl)methylcarbostyrils
CH607848A5 (da) * 1974-06-04 1978-11-30 Bayer Ag
GB1488411A (en) * 1975-01-16 1977-10-12 Wyeth John & Brother Ltd 3,4-dihydro-4-arylquinolin-4-ol derivatives
US4124587A (en) * 1976-03-01 1978-11-07 Sandoz, Inc. 4-Hydroxy-3-sulfinyl-quinolin-2(1H)-ones
US4127574A (en) * 1976-03-01 1978-11-28 Sandoz, Inc. 4-Hydroxy-3-sulfonyl-quinolin-2(1H)-ones
DE2616995A1 (de) 1976-04-17 1977-10-27 Bayer Ag 1.4-dihydropyridine mit schwefelhaltigen substituenten mehrere verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2616991A1 (de) 1976-04-17 1977-10-27 Bayer Ag Heterocyclisch-substituierte schwefelhaltige dihydropyridine, mehrere verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2639257A1 (de) 1976-09-01 1978-03-02 Bayer Ag Aminoalkylidenamino-1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2639498A1 (de) 1976-09-02 1978-03-09 Bayer Ag Neue schwefelhaltige amino-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2641746C2 (de) 1976-09-16 1986-11-06 Bayer Ag, 5090 Leverkusen 1,4-Dihydropyridin-Zuckerderivate, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE2658183A1 (de) * 1976-12-22 1978-07-06 Bayer Ag In 2-position substituierte 1,4- dihydropyridin-derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2658804A1 (de) 1976-12-24 1978-07-06 Bayer Ag Kreislaufbeeinflussende mittel
US4177278A (en) * 1977-04-05 1979-12-04 Bayer Aktiengesellschaft 2-Alkyleneaminodihydropyridines compounds, their production and their medicinal use
DE2715182A1 (de) 1977-04-05 1978-10-19 Bayer Ag 2-alkylenaminodihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
JPS5424882A (en) 1977-07-22 1979-02-24 Yamanouchi Pharmaceut Co Ltd Novel heterocyclic compounds and their preparation
DE2747513A1 (de) 1977-10-22 1979-05-03 Bayer Ag Dihydropyridine mit schwefelhaltigen estergruppierungen

Also Published As

Publication number Publication date
DE3011994C2 (da) 1991-06-27
CS221906B2 (en) 1983-04-29
US4302460A (en) 1981-11-24
PL223050A1 (da) 1981-01-30
IT8048262A1 (it) 1981-09-26
IT8048262A0 (it) 1980-03-26
YU84980A (en) 1983-09-30
IE49562B1 (en) 1985-10-30
HK94986A (en) 1986-12-12
IT1188916B (it) 1988-01-28
FR2468367A1 (fr) 1981-05-08
FI800923A (fi) 1980-09-28
DE3011994A1 (de) 1980-10-16
NO156787C (no) 1987-11-25
AT379390B (de) 1985-12-27
DD149608A5 (de) 1981-07-22
KR830001898A (ko) 1983-05-19
DK151252B (da) 1987-11-16
GR68007B (da) 1981-10-26
AU5670280A (en) 1980-10-02
ATA161880A (de) 1985-05-15
SG60886G (en) 1987-03-27
NZ193167A (en) 1984-08-24
MX6816E (es) 1986-08-05
FR2468367B1 (da) 1983-09-30
NL8001771A (nl) 1980-09-30
NL191306B (nl) 1994-12-16
FR2452484B1 (da) 1983-08-12
KR840001612B1 (ko) 1984-10-11
PH16758A (en) 1984-02-15
RO79397A (ro) 1982-06-25
DK130180A (da) 1980-09-28
EG16606A (en) 1989-01-30
CH644366A5 (fr) 1984-07-31
KE3649D (en) 1986-08-01
NO800881L (no) 1980-09-29
YU42332B (en) 1988-08-31
SE455422B (sv) 1988-07-11
MY8600668A (en) 1986-12-31
BG37836A3 (en) 1985-08-15
FI77026B (fi) 1988-09-30
IL59710A (en) 1984-01-31
FR2452484A1 (fr) 1980-10-24
HU179845B (en) 1982-12-28
FI77026C (fi) 1989-01-10
CA1151652A (en) 1983-08-09
IE800567L (en) 1980-09-27
DK151252C (da) 1988-05-16
BG37993A3 (en) 1985-09-16
PT71006A (en) 1980-04-01
DE3051205C2 (de) 1991-01-24
NL191306C (nl) 1995-05-16
PL124037B1 (en) 1982-12-31
AU536616B2 (en) 1984-05-17
NO156787B (no) 1987-08-17
SE8002345L (sv) 1980-11-14

Similar Documents

Publication Publication Date Title
LU82295A1 (fr) Agents therapeutiques et leur procede de preparation
EP0210084B1 (fr) Amides, procédés pour leur préparation et médicaments les contenant
EP0463945B1 (fr) Nouvelles chalcones, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
EP0527117A1 (fr) Cyclopropylamino-1,3,5-triazines substituées
EP0172096A1 (fr) Dérivés d'acylaminométhyl-3 imidazo[1,2-a]pyridines, leur préparation et leur application en thérapeutique
FR2645152A1 (fr) 3h-pteridinones-4, procedes de preparation et medicaments les contenant
CH674368A5 (da)
EP0040591A1 (fr) Dérivés de pyridoxine, leur procédé de préparation ainsi que leur utilisation en thérapeutique
CH655114A5 (fr) Derives de l'imidazotetrazinone, leur preparation et compositions pharmaceutiques les contenant.
FR2561647A1 (fr) Derives de 1-(hydroxymethyl)-1,6,7,11b-tetrahydro-2h,4h-(1,3)-oxazino- ou -thiazino(4,3,a)isoquinoleine, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2665441A1 (fr) Derives de la n-sulfonyl indoline, leur preparation, les compositions pharmaceutiques en contenant.
FR2647676A1 (fr) Nouveaux derives de pyridazinone, leurs procedes de preparation, medicaments les contenant, utiles notamment comme inhibiteurs de l'aldose reductase
EP0162776B1 (fr) Dérivés hétérocycliques, leurs procédés de préparation,médicaments les contenant, utiles notamment comme inhibiteurs de l'aldose réductase
EP0251937A1 (fr) Nouveaux dérivés tricycliques agonistes des récepteurs cholinergiques et médicaments en contenant
EP0463944B1 (fr) Acyl benzoxazolinones, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
CH650254A5 (fr) Quinolones, leurs procedes de preparation et compositions therapeutiques les contenant.
FR2600647A1 (fr) Derives de la glycine
LU80720A1 (fr) Polyfluorohydroxyisopropyl carbostyriles bicycliques et tricycliques antihypertensifs,leur preparation et compositions pharmaceutiques les contenant
CA1226284A (fr) Procede pour la preparation de derives de triazolo pyrimidine et les derives ainsi obtenus
EP0196943B1 (fr) Nouveaux dérivés 8-thiotétrahydroquinoléines et leurs sels
FR2565980A1 (fr) Nouveaux esters de 1,1-dioxydes de n-heteroaryl-4-hydroxy-2-methyl- 2h -1,2-benzothiazine- (ou thieno(2,3-e)-1,2-thiazine)-3-carboxamide precurseurs de medicaments et composition pharmaceutiques les contenant
EP0119896B1 (fr) Nouveaux dérivés de l'amino-5 dithiole-1,2 one-3, leur préparation et les compositions médicinales qui les contiennent
EP0395526B1 (fr) Nouveaux dérivés benzothiazolinoniques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
EP0017578B1 (fr) Acides 5-(2-hydroxy-3-thiopropoxy)chromone-2-carboxyliques, leurs sels et esters, procédé de préparation et médicaments
FR2531709A1 (fr) Diazabicyclooctanes, procede pour leur preparation et compositions pharmaceutiques les renfermant